Carregant...
Company accused of exploiting unique features of drug to retain market share
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group Ltd.
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2267965/ https://ncbi.nlm.nih.gov/pubmed/18340056 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.39517.383484.DB |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|